EXPERT SPEAKER PANEL. Director, Portfolio Management Biologics Dr. Reddy s Laboratories. CEO Enrich. Executive Program Director ImmunoGen

Similar documents
6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality

INCENTIVE COMPENSATION CONFERENCE

CHEM-E4140 Selectivity 12. Pharma Business

Clinical trial research agreement Agreed schedule 4 or 7 clause amendments

Oracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries

Orphan Pharma: pathfinders for an increasingly specialised industry

The World's Top 100 Pharmaceutical Companies

Global Non-Small Cell Lung Cancer Therapeutics Market

ROOT CAUSE ANALYSIS. Prevent Non-Compliance and Achieve Successful Root Cause Analyses and CAPA Systems Implementation from Clinical to Post-Market

Total Market Forecasting in Pharma USA

Global Peptide Therapeutics Market

ehealthinsight Series: Online Patient Recruitment Strategies

Stakeholder Perspectives: Mild Cognitive Impairment and Dementia

Campbell Alliance. Press Kit Materials

Biotech Outsource Strategies

Top ICT spenders in the US Pharmaceutical Industry - Estimated ICT budget breakdowns in 2013

4 th Annual Clinical Development and Trials Asia Congress. 5 th Annual Pharma R&D World Asia Congress

Groundbreaking Collaborative Clinical Trial Launched

Sarah A. Haecker, PhD 1782 Humboldt Avenue Minneapolis, Minnesota

Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus)

Sixth Annual. November 18-19, 2008 Hyatt Regency at Penn s Landing Philadelphia, PA. Risk

How Big Data Is Hoping To Power Predictive Analytics

PANAGORA PHARMA CUSTOMER EXPERIENCE SUMMIT 14

Pharmaceutical industry

Strategic Consulting Services

Global Monoclonal Antibodies Pipeline Insight 2015

The Gold Standard for Processing and Packaging

Outcomes of Monitoring Committee Reviews. Medicines Australia Code of Conduct

The Role of Regional Medical Advisor (RMA)-Field Medical. Dr. Aju Abraham Varghese Pfizer India. Feb 22 nd 2014

Avoca s Quality Metrics Consulting Service Offering

Due Diligence. Due Diligence Summit for Life Sciences 2 ND. Adam Muzikant. Carl Jessop Due Diligence Director, ASTRAZENECA. Alex Chang.

The Future of Monoclonal Antibodies Therapeutics: Innovation in Antibody Engineering, Key Growth Strategies and Forecasts to 2011

Cloud Marketing: Faces in the Cloud

2014 CORPORATE OVERVIEW

3:15 Networking and Refreshment Break. 3:45 Cloud Computing Manage Risk in a

BioPharma Analytics Informing every move

Biopharmaceutical Raw Materials throughout the Product Lifecycle

PROVENTA INTERNATIONAL INNOVATION. Strategies for Transforming Safety, Regulatory, and Benefit-Risk Management of Established Products

Join our scientific talent community

2016 Sponsorship Opportunities

Training and Employment Opportunities in the Biopharma Industry

Biotie Therapies Corp

Medical Science Liaison (MSL): Understanding, Engaging and Interacting. Gill Logan Regional Medical Affairs Manager Takeda UK

3rd Annual Patient Recruitment & Retention in Pharma

Biosimilar Monoclonal Antibodies in the Pipeline: Major Players and Strategies

Annual Press Conference Business Year 2011

The Texas Biotechnology Industry

THE BIOTECH & PHARMACEUTICAL INDUSTRY

Blockbuster!!! Content Management in the Pharmaceutical Industry An Overview. Global Pharma Market Shares by Sales (Approx. USD 700 Billion) Global

Commercial Insight Osteoarthritis and Rheumatoid Arthritis

Transforming relationships Unleashing innovation

Bridging Clinical Trial Innovation and Quality

The power of creativity Pharmaceutical Branding 2012

China Medical Equipment Market Analysis and Forecasts to 2015

1) SCOPE OF THE PROGRAM

Creating Joint Value. In Biopharma and Many Other Industries, Not Invented Here Is SO Last Century. By Ben Gomes-Casseres

2014 & 13 th Annual China Pharmaceutical, Life Science & Healthcare Industry Summit

Osteoporosis Drug Development Moving Forward Public Workshop

Investors' Access. Market. Strategic. Forum. Open. E-Health PROGRAM Alliance. Innovation PRELIMINARY. Management

Biometrics: Clinical Trials and Beyond

KEEPING CLINICAL TRIALS IN AUSTRALIA

CANADA. The Premier Procurement and Strategic Sourcing Event. March 17-19th, 2014 Toronto, Canada Hyatt Regency. Event Highlights CANADA

Pharmaceutical sales in Canada have a 2.5 percent share of the global market, making th

Leadership for Drug Development Teams

2014 EVENT HIGHLIGHTS

2012 National BDPA Technology Conference. Defining Project and PMO Metrics

How Global Data Management (GDM) within J&J Pharma is SAVE'ing its Data. Craig Pusczko & Chris Henderson

Stakeholder Insight: Insulin Use in Type 2 Diabetes

Published by Waterford Life Sciences, Washington, DC Cover and book design: Gretchen Maxwell, GLM Design

Acknowledgements. We thank these organizations and individuals for their unrestricted support.

Notice of Annual General Meeting

IDC US UPCOMING EVENT CALENDAR

Lilly Covance Strategic Alliance From Vision to Results. Adrienne Takacs, PhD Jonathan Koch, MBA

Life Sciences Outlook. New Jersey 2015

Digital Leaders Deal With a Range of Organizational Challenges

Evaluating Business Intelligence Opportunities in the Pharmaceutical Industry (Strategy Focus)

Rising importance of Business Analysis when performing projects

JOHN REID PhD, MBA. (302)

Profile of Biomedical Research and Biotechnology Commercialization. Los Angeles-Riverside-Orange County Consolidated Metropolitan Statistical Area

June Washington, DC SPONSORSHIP OPPORTUNITIES

The Linux Foundation and Its Event Production

BIOTECHNOLOGY. Bouvé College of Health Sciences College of Science. Networked for Success. Networked for Industry. Networked for Life.

Governance. Execution. Value.

How To Understand And Understand Biosimilars

sponsorship and exhibitor prospectus July 25-26, 2016 seaport boston Boston, MA

THE VIRAL HEPATITIS CONGRESS September 2015, Kap Europa, Frankfurt, Germany THE VIRAL HEPATITIS CONGRESS. Scientific Programme

Partnering for scientific leadership

M&A und Allianzen in Life Science Aktuelle Entwicklungen und Trends

FOR SUCCESS YOUR PRESCRIPTION SPEAK. Business

Life Sciences Outlook. Philadelphia 2015

PMI Mass Bay Chapter Call for Speakers

Accelerating Drug & Clinical Trial Approvals in China & East Asia

Health Reform s New Frontier: Balancing Cost, Value and Innovation

TRENDS SHAPING THE FUTURE OF PERSONALIZED CARE AND THE DELIVERY OF SPECIALTY PHARMACY

Biopharmaceutical Raw Materials throughout the Product Lifecycle. Biosimilars and Biobetters Development & Production.

Profile of Biomedical Research and Biotechnology Commercialization. Boston-Worcester-Lawrence Consolidated Metropolitan Statistical Area

Biomanufacturing Vision for the Future

CONFERENCE PROGRAMME D R I V I N G Success ACDM Annual Conference 2010

Rx-360 An International Pharmaceutical Supply Chain Consortium

Project Management Excellence in Life Sciences: Balancing Art and Science

Transcription:

www.americanleaders.com 8 th Project and Portfolio Management for Pharma & Biotech Leveraging the Catalysts of Portfolio Success October 6-7, 2015 Hyatt Regency Boston Post-show report EXPERT SPEAKER PANEL CHAIRPERSON: Frank Makosiej Covance Executive Director, Operational Strategy and Planning Sean (Yong) Xue Director, Portfolio Management Biologics Dr. Reddy s Laboratories Peter Heinrich President & CEO PDWare Usman Iqbal, MD, MPH, MBA Sr. Medical Affairs Leader- ING, Global Medical Affairs AstraZeneca Richard Sonnenblick CEO Enrich Christopher Beck VP Schedule and Resource Decision Analytics Shire Karen Graham, PMP Senior Director, Project Management, Oncology Portfolio Leader Covance Julio Gagne Executive Program Director ImmunoGen Matt McLeod Senior Director, Development Team Program Lead Tesaro Frank Makosiej Executive Director, Operational Strategy and Planning Covance Sultan M. Aziz Senior Director, Head of Capacity Management Janssen Pharmaceutical Companies of Johnson & Johnson Grant Morgan SVP Portfolio Planning, Systems & Analytics BTG International Sanjeev Ramabhadran Director, Project and Portfolio Management Daiichi Sankyo Pharma Development David Townson Head, Program Office, Cell and Gene Therapies Novartis Mark Mlynarczyk Senior Director, Portfolio Operations, Strategy & Management MedImmune

Table of contents Page 2 Page 3 Page 4 Page 5 Table of contents About the 8th annual Key sessions of the conference + delegate breakdown Sponsor and delegate list

About the 8 th Annual For the eighth time, senior executives from the pharma and biotech industries gathered in October 2015 at the Hyatt Regency in downtown Boston for one of the longest-running American Leaders conferences. The speaker panel 8th Annual Project and Portfolio Management for Pharma and Biotech, chaired by Covance s Executive Director, Frank Makosiej, featured senior executives from the biggest names in the industry: including companies such as AstraZeneca, Novartis or Daiichi Sankyo. The two-day program was split into interactive sessions, providing delegates with practical solutions to the biggest issues in today s pharma PPM. Special focus was placed on strategic alignment thanks to the Building an Action Plan feature. After each session, delegates were dedicated space to work on implementing the newly-gained knowledge in their companies and to discuss strengths, weaknesses and limitations. During the two conference days, delegates discussed their opinions and shared their experience on portfolio risk management, decision-making, prescriptive modelling and data analysis for pharma portfolios, among other topics. When asked about their opinions on the event, this is what the attendees had to say: The Venue: This luxury Boston hotel features 30,000 square feet of elegant and flexible function space with innovative audiovisual equipment, hotel-wide Wi-Fi access and creative catering menus. With a combination of awardwinning service and custom amenities, Hyatt Regency Boston is the premier hotel for business travelers. The sharing of information across companies is key for the long-term health of the industry. This conference allows for a litmus test for your own company. Vincent Agresto Senior Project Associate, Program Management Systems & Operations Regeneron An incredibly insightful event and collection of industry thought leaders. Matt Killeen, PhD., Associate Director, Portfolio Strategy and Competitive Intelligence BioMarin The American Leaders meeting provided attendees with an excellent blend of actionable ideas that can be applied across many types and sizes of organizations. David Townson Executive Director, Global Program Team Director and Program Management Site Head Novartis Oncology Interesting cross-section of topics and stakeholders around the industry! Sanjeev Ramabhadran Director, Project & Portfolio Management Global Project Management & Leadership Daiichi Sankyo, Inc. The conference was initimate and ultimately informative. I, personally, have several ah-ha moments that I will take back to my company. Grant Morgan Senior Vice President, Portfolio Panning, Systems & Analytics BTG International

Key sessions of the 8 th Annual There were several hot topics presented and discussed in detail at the 8th Annual Project & Portfolio Management for Pharma and Biotech. Here are some of the sessions that were met with the best feedback from this year s delegates: Daiichi Sankyo s case study on examining progression of a project s viability at each stage of the life cycle Novartis presented their own tested methodology on employing micro-funding strategies to increase portfolio flexibility AstraZeneca illustrated evidence-based approaches to manage portfolio risk and prioritization in their breakout session Roundtable discussion on portfolio and resource planning integration Spotlight session on portfolio planning and execution Case study on predictive and prescriptive modeling to help drive portfolio optimization, presented by Janssen & Janssen Dedicated networking sessions with project, portfolio and resource management decision makers Job title distribution: 68% Directors/General Managers 25% Managers/Heads of Departments 7% Specialists

MEET OUR PARTNERS Silver Sponsors PDWare is a provider of resource planning and portfolio management software. ResourceFirst, our flagship PPM product, helps organizations improve operations through a combination of resource forecasting, capacity planning, time tracking, status reporting and financial analysis. ResourceFirst is available for cloud and on-premise installations, providing first-line managers, executives, PMOs and EPPMOs the agility to meet fluctuating work priorities, capacity and demand. PDWare customers include Medtronic, BD, Cablevision, Regeneron, SIG, Motorola, Philips, Stryker and Tektronix. Enrich was born out of a restless desire to help companies do more create more game-changing technology, develop more life-saving drugs, find more opportunity. For our clients, we build transparency into the decisions that drive their business forward. The Enrich Analytics Platform (EAP) provides the enterprise computing power; our high-touch, one-on-one approach builds the custom solutions that empower clients to make strategic business decisions and follow through on them. Media Partners

Company Jobtitle Country AbbVie Director, Project Office USA AbbVie Assistant Director, Planning & Portfolio Support USA Abbott Diagnostics Director, Portfolio Management USA Acetylon Pharmaceuticals Senior Director, Program Management USA Adamas Pharmaceuticals Senior Director USA Adamas Pharmaceuticals Vice President USA Aegerion Pharmaceuticals Director, Program Management USA Aegerion Pharmaceuticals Senior Director, Program Management USA Alexion Pharmaceuticals Project Manager USA Alexion Pharmaceuticals Project Planner USA Alexion Pharmaceuticals Senior Director USA Alkermes Senior Financial Analyst Ireland Alkermes Senior Director, Strategic Planning & Portfolio Management Ireland Allergan Manager, Portfolio Analysis USA Allergan Business Analytics Manager USA Amgen Manager, Strategic Planning & Operations USA Amgen Director, Pipeline Strategy & Portfolio Management USA Aptalis Pharma Senior Director, Project Management USA AstraZeneca Head, Business Operations Neuroscience USA Baxalta Senior Director, Business Operations Global Project Management USA BIND Therapeutics Project & Portfolio Professional USA BioMarin Pharmaceuticals Senior Director USA BioMarin Pharmaceuticals Senior Director USA BioMarin Pharmaceuticals Associate Director USA BioMarin Pharmaceuticals Assistant Director, Portfolio Strategy USA Boston Scientific Senior Manager, Corporate Portfolio USA CNRC-IRB Director Canada Covance Director, Portfolio Management USA Covance Senior Director, Portfolio Management USA Covidien Manager, Strategy & Portfolio USA

Eisai Executive Director, Global Oncology Business Unit USA Eli Lilly Advisor, Portfolio Planning USA Emergent BioSolutions Senior Director, Scientific Services USA Eureka Therapeutics Head USA Genetech Global Manager, PMO, Producer, Portfolio Management USA Genetech Cross Portfolio Governance USA Genetech Manager, Portfolio Management, USA Oncology Pipeline & Portfolio Planning Genetech Ophthalmology Franchise Lead, Pipeline & Portfolio Planning USA Genzyme Manager, Portfolio & Development Operations USA Gilead Director, Planning & Portfolio Analysis USA Gilead Associate Director USA Green Cross Corporation Deputy General Manager South Korea Green Cross Corporation Manager South Korea Grifols Head, Project Management USA Helsinn Therapeutics Manager, Project Management & Planning USA Impax Laboratories Senior Director, Portfolio Management USA Impax Laboratories Associate Director, Strategic Portfolio Management USA Integrated Project Management Business Development Executive USA Jazz Pharmaceuticals Senior Director, Project Management USA Johnson & Johnson Innovation Director USA Johnson & Johnson Innovation Global Portfolio Manager USA Juno Therapeutics Program Manager USA Juno Therapeutics Senior Director, Program/Alliance USA Life Technologies/Thermo Fisher Head, Program Management Office USA MedImmune Senior Project Manager USA Merck Associate Director USA Millenium Pharmaceuticals, Portfolio Manager USA The Takeda Oncology Company Millenium Pharmaceuticals, Director, Drug Development Manager USA The Takeda Oncology Company Novartis Executive Director USA NPS Pharmaceuticals Director, Project Management USA

NPS Pharmaceuticals Senior Director, Project Management USA OncoMed Pharmaceutical CMC Team Leader USA Onyx Pharmaceuticals Senior Manager USA OvaScience Associate Manager, Program Management USA Perrigo Director USA Perrigo Director, Stage Gate USA Regeneron Pharmaceuticals Director USA Regeneron Pharmaceuticals Senior Project Associate USA Roche Head, Strategy & Portfolio, Switzerland Pharma Reserach & Early Development SciClone Pharmaceuticals Assistant Project Manager USA Seattle Genetics Inc. Senior Director, Programs & Alliance Management USA Shire Pharmaceuticals Associate Director USA Smith and Nephew Senior Project Manager USA Sunovion Pharmaceuticals Associate Director USA Sunovion Pharmaceuticals Director USA Sunovion Pharmaceuticals Senior Director USA Takeda Pharmaceuticals Associate Director, Portfolio Management USA Takeda Pharmaceuticals Associate Director, Global Project Management USA & Drug Development Management Taris Biomedical Director, Program Management USA Teva Pharmaceuticals Group General Manager USA Vertex Pharmaceuticals R&D Program Manager USA Vertex Pharmaceuticals Director USA X-gen Director USA XOMA Ltd. Senior Project Manager USA XOMA Ltd. Associate Director USA XOMA Ltd. Director USA XOMA Ltd. Associate Director, Project & Alliance Management USA